Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and

Burke A Cunha1

  • 1State University of New York School of Medicine, Stony Brook, NY, USA.

Insights

Antibiotic resistance in Streptococcus pneumoniae, Enterococcus, and Staphylococcus is a growing concern. Understanding antibiotic susceptibility testing is crucial for effective treatment of these resistant bacterial infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Rising antibiotic resistance in key bacterial pathogens like Streptococcus pneumoniae, Enterococcus, and Staphylococcus presents significant clinical challenges.
  • The increasing prevalence of multidrug-resistant strains necessitates a thorough understanding of antimicrobial susceptibility patterns.

Purpose of the Study:

  • To review the clinical significance of antibiotic resistance in Streptococcus pneumoniae, including penicillin, macrolide, and multidrug resistance.
  • To discuss the therapeutic approaches for Enterococcus faecalis (vancomycin-sensitive enterococci) and Enterococcus faecium (vancomycin-resistant enterococci).
  • To compare treatment strategies for methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) infections, including hospital-acquired (HA-MRSA) and community-acquired (CA-MRSA) strains.

Main Methods:

  • Literature review and synthesis of current clinical guidelines and research.
  • Analysis of antibiotic susceptibility testing principles and interpretation.
  • Comparative review of therapeutic options for specific resistant bacterial infections.

Main Results:

  • Penicillin-resistant, macrolide-resistant, and multidrug-resistant Streptococcus pneumoniae strains pose distinct clinical challenges.
  • Distinct therapeutic strategies are required for vancomycin-sensitive Enterococcus faecalis versus vancomycin-resistant Enterococcus faecium.
  • Differences in treatment exist between MSSA and MRSA, with specific considerations for HA-MRSA and CA-MRSA.

Conclusions:

  • Effective management of infections caused by resistant pneumococci, enterococci, and staphylococci hinges on accurate antibiotic susceptibility testing and tailored therapeutic choices.
  • Clinicians must be adept at interpreting susceptibility data to optimize antibiotic selection for these challenging pathogens.
  • Understanding the nuances between in vitro susceptibility and in vivo efficacy, particularly for MRSA, is critical for successful patient outcomes.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...